Page 132 - 2021_06-Haematologica-web

S. Cordes et al.
al. Inhibition of vascular endothelial cell
leak following Escherichia coli attachment in an experimental model of sepsis. Crit Care Med. 2018;46(8):e805-e810.
58. Han S, Lee SJ, Kim KE, et al. Amelioration of sepsis by TIE2 activation-induced vascu- lar protection. Sci Transl Med. 2016;8(335):335ra355.
59. Wojciak-Stothard B, Tsang LY, Haworth SG. Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation- induced permeability changes in pul- monary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2005;288(4):L749-760.
60.Dias AT, Cintra AS, Frossard JC, et al.
Inhibition of phosphodiesterase 5 restores endothelial function in renovascular hyper- tension. J Transl Med. 2014;12:250.
61. Chen W, Oberwinkler H, Werner F, et al. Atrial natriuretic peptide-mediated inhibi- tion of microcirculatory endothelial Ca2+ and permeability response to histamine involves cGMP-dependent protein kinase I and TRPC6 channels. Arterioscler Thromb Vasc Biol. 2013;33(9):2121-2129.
62. Guilluy C, Sauzeau V, Rolli-Derkinderen M, et al. Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension. Br J Pharmacol. 2005;146(7):1010-1018.
63. Das A, Xi L, Kukreja RC.
64.
65.
Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J Biol Chem. 2005;280(13):12944-12955.
Fukumoto S, Koyama H, Hosoi M, et al. Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation. Circ Res. 1999;85(11):985-991.
Zeiser R, von Bubnoff N, Butler J, et al. Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease. N Engl J Med. 2020;382(19):1800-1810.
2160
haematologica | 2021; 106(8)